Mainz Biomed (MYNZ) Change in Receivables (2021 - 2024)
Historic Change in Receivables for Mainz Biomed (MYNZ) over the last 4 years, with Q2 2024 value amounting to $139414.0.
- Mainz Biomed's Change in Receivables fell 6241.51% to $139414.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $139414.0, marking a year-over-year decrease of 6241.51%. This contributed to the annual value of $64278.0 for FY2024, which is 3129.39% down from last year.
- Per Mainz Biomed's latest filing, its Change in Receivables stood at $139414.0 for Q2 2024, which was down 6241.51% from $93555.0 recorded in Q4 2023.
- Over the past 5 years, Mainz Biomed's Change in Receivables peaked at $449441.0 during Q1 2023, and registered a low of -$184428.0 during Q1 2022.
- In the last 4 years, Mainz Biomed's Change in Receivables had a median value of $199276.0 in 2022 and averaged $196601.4.
- Within the past 5 years, the most significant YoY rise in Mainz Biomed's Change in Receivables was 34369.46% (2023), while the steepest drop was 6389.76% (2023).
- Quarter analysis of 4 years shows Mainz Biomed's Change in Receivables stood at $111842.0 in 2021, then surged by 131.7% to $259138.0 in 2022, then plummeted by 63.9% to $93555.0 in 2023, then skyrocketed by 49.02% to $139414.0 in 2024.
- Its Change in Receivables was $139414.0 in Q2 2024, compared to $93555.0 in Q4 2023 and $370931.0 in Q2 2023.